Plain English with Derek Thompson15 Des 2023

How Weight-Loss Drugs Could Impact U.S. Healthcare and Food. Plus, the Biggest Problems With GLP1s.

Today’s episode is our second in a series on the weight-loss drug revolution of the last two years. On Tuesday, we talked to endocrinologist Beverly Tchang about the science of glucagon like peptide 1 receptor agonists—also known as GLP1s, also known as Ozempic, Wegovy, Moujargo, and Zepbound. If you haven’t listened to that show, I think you’ll feel safe and entertained within the bounds of this episode. But if you want to know more about how these drugs work, their effect on insulin and glucose and the brain’s reward center, or the questions they raise about obesity and the nature of willpower and free will, I’d encourage you to queue up that show. Today, in Part 2, we have two guests: Zach Reitano is the CEO and cofounder of the telehealth platform Ro. He is here for a couple reasons. He has a bird’s-eye view of the GLP1 marketplace, the rise in demand, the supply chain, the economics of pricing and insurance. He’s also written several revelatory essays, pulling in research from think tanks, medical experts, and investment banks, that have helped shape my understanding of these drugs and the effect they could have on the population and the economy. Our second guest is Dr. Robert Lustig, an endocrinologist who spent years as a pediatrician and researcher at the University of California-San Francisco. As you’ll hear, he is much less optimistic about the ability of these drugs to revolutionize obesity medication in America. If you have questions, observations, or ideas for future episodes, email us at PlainEnglish@Spotify.com. Host: Derek Thompson Guests: Zach Reitano & Robert Lustig Producer: Devon Baroldi Learn more about your ad choices. Visit podcastchoices.com/adchoices

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(405)

The Single Smartest Case Against AI Doom

With new breakthroughs in math and biology alongside reports of AI agents escaping and hacking systems, suffice it to say AI has had an interesting few weeks. How worried should we be about it all? D...

25 Sep 1h 1min

The Truth About Mississippi's Education "Miracle"

Education outcomes have been getting worse across much of the world, with reading and math scores falling to historic lows. The U.S. has seen some of the steepest declines in decades. But, why does ...

18 Sep 56min

Why Experts Keep Getting the Economy So Wrong

Expert economists keep making predictions about America’s financial future, and those predictions keep being … wrong. Over the past few years, we’ve heard warnings about a recession, inflation, tariff...

15 Sep 58min

What’s the Point of College?

Trust in American higher education is near a historic low. Tuition has soared, and the payoff for a college degree is now in question as graduates face a weird and challenging job market. Simultaneous...

11 Sep 56min

The New Book That Scares Big Tech

In the late 19th century, a railroad boom fueled by easy money, speculative investment, and new technology helped kick off one of the worst financial crises in American history. Sound kind of familiar...

8 Sep 59min

AI Slop Is Breaking the Internet. Can We Save It?

So many people seem to hate AI, and it’s not just because it might displace millions of jobs, destroy the world, or deepen distrust in big corporations and government. The reason might actually be sim...

1 Sep 56min

Why Everything Is Going to Keep Getting More Expensive

For much of the 21st century, the U.S. economy was built around cheap money. Today, though, interest rates are rising, and borrowing is getting much more expensive. At the same time, the federal gover...

25 Aug 41min

Higher Education’s Age of ‘Insufferable Hypocrisy’

It would be an understatement to say that higher education is in crisis, as it faces attacks from both the current presidential administration as well as issues of its own making, like diversity polit...

18 Aug 1h 2min